SNNA
Sienna Biopharmaceuticals, Inc.
SNNA
SNNA
Delisted
SNNA was delisted on the 16th of December, 2019.
52 hedge funds and large institutions have $184M invested in Sienna Biopharmaceuticals, Inc. in 2018 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 27 increasing their positions, 8 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
52
Holders Change
+9
Holders Change %
+20.93%
% of All Funds
1.19%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
14
Increased
27
Reduced
8
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
BlackRock
New York
|
+$7.68M |
| 2 |
WCM
Wildcat Capital Management
New York
|
+$5.55M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.39M |
| 4 |
State Street
Boston,
Massachusetts
|
+$3.02M |
| 5 |
Morgan Stanley
New York
|
+$2.94M |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
51
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| $2K | – | – | – |
|
52
Daiwa Securities Group
Tokyo,
Japan
| $2K | +$2K | +113 | New |
|
|
ACM
53
Asymmetry Capital Management
San Francisco,
California
| – | -$484K | -26,692 | Closed |
|
|
PCM
54
Prelude Capital Management
New York
| – | -$254K | -13,974 | Closed |
|
|
TCIM
55
TIAA CREF Investment Management
New York
| – | -$135K | -7,433 | Closed |
|
|
TRCT
56
Tower Research Capital (TRC)
New York
| – | -$18K | -975 | Closed |
|
57
Parallax Volatility Advisers
San Francisco,
California
| – | -$14K | -756 | Closed |
|